Extendicare Inc. (TSE:EXE – Get Free Report)’s stock price reached a new 52-week high on Tuesday . The stock traded as high as C$23.22 and last traded at C$22.89, with a volume of 72764 shares changing hands. The stock had previously closed at C$22.75.
Analysts Set New Price Targets
Several brokerages have commented on EXE. Canaccord Genuity Group upped their price objective on shares of Extendicare from C$20.00 to C$22.50 in a report on Thursday, December 4th. Natl Bk Canada upgraded shares of Extendicare to a “strong-buy” rating in a research report on Wednesday, December 3rd. Royal Bank Of Canada upgraded shares of Extendicare from a “hold” rating to a “moderate buy” rating and raised their price objective for the stock from C$15.00 to C$25.00 in a report on Thursday, December 4th. CIBC lifted their price objective on Extendicare from C$18.00 to C$22.00 in a research report on Thursday, November 13th. Finally, Cormark upped their target price on Extendicare from C$25.00 to C$30.00 in a report on Wednesday, December 3rd. Three research analysts have rated the stock with a Strong Buy rating, four have assigned a Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat.com, Extendicare currently has a consensus rating of “Buy” and an average target price of C$23.86.
Get Our Latest Report on Extendicare
Extendicare Trading Up 0.2%
Extendicare Announces Dividend
The business also recently declared a monthly dividend, which was paid on Monday, November 17th. Stockholders of record on Monday, November 17th were issued a dividend of $0.042 per share. The ex-dividend date was Friday, October 31st. This represents a c) annualized dividend and a dividend yield of 2.2%. Extendicare’s dividend payout ratio (DPR) is presently 46.60%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- NEW LAW: Congress Approves Setup For Digital Dollar?
- The $100 Trillion AI Story No One Is Telling You
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.
